Stories about DNA

Subscribe to topic

Subscribe to DNA

16.01.2020 – 12:51
Technische Universität München
Self-assembled complex porous, chiral nano-patterns arise from a simple linear building block
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35868/ High resolution images: https://mediatum.ub.tum.de/1535044 NEWS RELEASE Pretty with a twist Complex porous, chiral nano-patterns arise from a simple ...
more
17.12.2019 – 15:30
Skytec Group Ltd
Skytec Group Ltd assumes control of traditional electronics firm LOEWE
Bratislava (ots) - "Made in Germany" with love and passion: Award-winning manufacturers of smart entertainment solutions is taken over by Skytec Almost 100 years, Germany has boasted LOEWE, the most exquisite yet understated entertainment systems designer for televisions. Renowned for its accuracy in manufacturing, LOEWE has a staggering track record of 'firsts' ...
more
16.12.2019 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics announces first results of tissue-independent liquid biopsy for early stage breast cancer mutation characterization and monitoring using ultra-sensitive SafeSEQ technology
Hamburg, Germany and Baltimore, Maryland (ots) - New data presented by Dr. Ben Ho Park, Professor of Medicine and Director of Precision Oncology at Vanderbilt University and colleagues at the recent San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas demonstrated a potential utility for monitoring ...
more
04.12.2019 – 12:42
Lancôme Paris
Lancôme's First Flagship Finds New Address at 52 Champs-Élysées in Paris
Paris (ots/PRNewswire) - The French luxury beauty brand inaugurates its new flagship store on the prestigious Champs-Élysées in the heart of Paris. 52 Avenue des Champs-Elysées is an address imbued with historical prestige and is the new home of happiness for Lancôme, a new place for beauty and happiness where visitors can discover the brand's world, experiment, ...
more
05.11.2019 – 09:03
Aston Martin Lagonda of Europe GmbH
4
The AMB 001 by Aston Martin and Brough Superior
more
One document
24.10.2019 – 11:48
Aston Martin Lagonda of Europe GmbH
Aston Martin and Brough Superior to collaborate on limited edition motorcycles
more
One document
18.10.2019 – 07:30
Braathens Regional Airlines
Carbon offsetted flights Berlin - Sweden as Braathens Regional Airlines open two new routes direct to Malmoe and Gothenburg
Stockholm (ots) - As from 30 March will Braathens Regional Airlines operate daily Berlin Tegel Airport - Gothenburg, and twice a week Berlin Tegel - Malmoe. Flight tickets www.flygbra.se/en start at 60 EUR, one way to Malmoe, and 65 EUR to Gothenburg. All flights are always fully carbon offsetted. It is the demand ...
more
11.10.2019 – 10:00
REC Group
REC Group Kicks Off Mass Production of Its Ground-breaking Alpha Module in Singapore
Tuas, Singapore (ots/PRNewswire) - REC Group's Alpha Series with HJT technology and a patented panel design rolls off the lines on October 10 at the manufacturing site in Singapore. Being the highest power 60-cell module, this marks a significant step for REC and the whole solar industry. With the Alpha, REC once again demonstrates its commitment to empower consumers ...
more
01.10.2019 – 07:37
Wirecard AG
Wirecard launches first fully digital multi-merchant loyalty solution
Aschheim (Munich) (ots) - - Cross-functional loyalty solution from Wirecard is the first digital wallet which links payment and loyalty - Companies can drive additional revenue growth with partners from multiple industry sectors - Solution brings real added value for consumers by extending "earn and burn" offerings - Wirecard expects strong traction, especially within ...
more
27.09.2019 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics launches two NGS-based liquid biopsy panels for cancer therapy drug development
Hamburg, Germany and Baltimore, Maryland (ots) - Sysmex Inostics announces the availability of the SafeSEQ Breast Cancer and Head and Neck Cancer Panels along with the SafeSEQ Rapid Custom Development program for circulating tumor DNA (ctDNA) analysis. SafeSEQ is a next-generation sequencing (NGS)-based approach that delivers sensitivity comparable to the clinically ...
more
23.09.2019 – 08:01
Merck KGaA
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
Darmstadt, Germany (ots/PRNewswire) - Not intended for distribution in the USA, Canada or the UK Key ESMO Abstracts # BAVENCIO® (avelumab): 1451; 3152; 4174; 4256; 4823; 5113, ERBITUX® (cetuximab): 1212, 2589, 4455, Tepotinib (MET kinase inhibitor): 3930; 5373; 5455, M6620 (ATR inhibitor): 1547, Combinations: ...
more
19.09.2019 – 20:07
MAKE UP FOR EVER
/C O R R E C T I O N -- Make Up For Ever/
Paris (ots/PRNewswire) - In the news release, MAKE UP FOR EVER, in the Presence of the President and CEO Garbrielle Rodriguez, Is Celebrating Its Make Up Artist Collective With the Artists Rock! Event in Paris From September 18th to 20th, 2019, issued 19-Sep-2019 by Make Up For Ever over PR Newswire, we are advised by the company that the name in the headline should read "Gabrielle Rodriguez" rather than as originally ...
more
19.09.2019 – 17:41
MAKE UP FOR EVER
MAKE UP FOR EVER, in the Presence of the President and CEO Garbrielle Rodriguez, Is Celebrating Its Make Up Artist Collective With the Artists Rock! Event in Paris From September 18th to 20th, 2019
Paris (ots/PRNewswire) - Embark on the journey and discover the biggest co-creation live event ever MAKE UP FOR EVER is THE brand of professional makeup artists. Since its creation, Dany Sanz, Founder of MAKE UP FOR EVER, has always collaborated with them and over the years has built a complementary strong ...
more
04.09.2019 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging
Hamburg/Baltimore (ots) - Using Sysmex Inostics' novel SafeSEQ next-generation sequencing cell-free DNA technology, investigators from the Biomedical Research Institute of Malaga [(IBIMA)-CIMES-UMA, Malaga Spain] and collaborators have published the first pilot study to examine the use of a non-invasive liquid ...
more
13.08.2019 – 14:15
Helmholtz Zentrum München
BART-Seq: A Novel Method to Characterize Genes with High-Precision in Single Cells
The analysis of gene products in cells is an important tool for diagnosing disease and the design of new active substances in biological and medical research. At Helmholtz Zentrum München, a method of targeted RNA sequencing (transcriptome analysis) has now been developed, which precisely detects the smallest amounts of gene transcripts in single cells. The method ...
more
02.08.2019 – 08:00
Sysmex Inostics GmbH
Sysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer
Kobe, Japan (ots) - Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM(TM) RAS CRC Kit, used for blood-based circulating tumor DNA (ctDNA) molecular testing of mutations in the RAS gene for advanced colorectal cancer patients. With clinically-validated high sensitivity and ...
more
18.07.2019 – 12:00
Sysmex Inostics GmbH
Liquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
Hamburg, Germany (ots) - Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces publication of a study comparing the performance of plasma RAS mutation detection by two commercial liquid biopsy testing platforms, the OncoBEAM(TM) ...
more
03.06.2019 – 09:00
Debiopharm International SA
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)
Irving, Texas (ots) - Caris to develop CDx for Debiopharm's FUZE Phase II Pivotal Trial of Debio 1347 in solid tumor patients with FGFR fusions Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic ...
more
30.05.2019 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics OncoBEAM(TM)-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study
Hamburg/Baltimore (ots) - Sysmex Inostics announces the publication of clinical research conducted as part of the CIRculating CANcer (CIRCAN) Program at the Lyon Cancer Institute (Lyon, France) comparing the performance of Sysmex Inostics BEAMing (beads, emulsion, amplification, and magnetics) assay for EGFR ...
more
28.05.2019 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics' SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM(TM) enhanced digital PCR technology for detection of mutations in circulating tumor DNA
Hamburg/Baltimore (ots) - Recent data presented by Dr. Hope S. Rugo from the University of California San Francisco on behalf of investigators in the Translational Breast Cancer Research Consortium at the American Association of Cancer Research 2019 meeting in Atlanta, Georgia demonstrate how Sysmex Inostics' novel ...
more
21.05.2019 – 10:21
Technische Universität München
How molecular escorts help prevent cancer: Chaperones keep the tumor suppressor protein p53 in check
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/article/35454/ High resolution images: https://mediatum.ub.tum.de/1487157 NEWS RELEASE How molecular escorts help prevent cancer Chaperones keep the tumor ...
more
26.04.2019 – 10:00
Indivumed GmbH
Ingress-health and Indivumed Announce an International Partnership on Real-World Evidence Studies in Oncology
more
11.04.2019 – 14:15
Horizon 2020 - Open to the World
Horizon Europe: The biggest Research and Innovation programme you've never heard of
Brussels (ots) - 'Horizon Europe must be more than a science programme; it needs to be the cornerstone for a new 'social contract' between citizens, governments and science.' [1] Horizon Europe, the European Union's next Research and Innovation (R&I) Programme, will run for seven years, from 2021 to 2027. With a proposed budget of EUR94.6 billion, it is the EU's ...
more
02.04.2019 – 09:25
Helmholtz Zentrum München
New machine learning model describes dynamics of cell development
From their birth through to their death, cells lead an eventful existence. Thanks to single-cell genomics, their destiny in large cell populations can now be analyzed. However, this method destroys the cell, which makes it difficult to draw conclusions about the dynamics of cell development. In order to address this problem, researchers at the Helmholtz Zentrum ...
more
30.03.2019 – 01:02
Merck KGaA
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral Treatment for Relapsing-Remitting and Active Secondary Progressive Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - MAVENCLAD is the first oral MS treatment to provide two years of proven efficacy with a maximum of 20 days of treatment - MAVENCLAD's unique mechanism may provide an important new option for patients with ongoing active disease - MAVENCLAD demonstrated significant efficacy ...
more
28.03.2019 – 10:20
THOMAS SABO GmbH & Co.KG
Premiere: THOMAS SABO designs its first Eyewear Collection
more
25.03.2019 – 12:04
Merck KGaA
MAVENCLAD® (Cladribine Tablets) Approved As The First Short-Course Oral Treatment for Relapsing Remitting Multiple Sclerosis in Switzerland
Darmstadt, Germany (ots/PRNewswire) - - MAVENCLAD® is now approved in 52 countries worldwide - Approval brings forward new treatment option with a novel mechanism for highly active relapsing multiple sclerosis in Switzerland - Approval based on extensive clinical development program capturing more than 10,000 ...
more

12Next